Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Starboard
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
Starboard’s stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand for its Covid-19 medicines recedes.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Activist Starboard Value Takes $1 Billion Stake in Pfizer
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Activist Investor Starboard Value Accuses Pfizer Of Pressure Former Execs To Halt Support For Its...
Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt support for Starboard’s turnaround campaign. Starboard’s Jeff Smith revealed the company allegedly threatened to claw back compensation and cancel unvested shares.
1d
on MSN
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
2d
on MSN
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
pharmaphorum
5d
Starboard claims Pfizer 'threatened' former leaders
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Crain's New York
5d
Pfizer's ex-CEO won't be involved in Starboard Value effort
Ex-CEO Ian Read and former CFO Frank D’Amelio said they are “fully supportive” of Pfizer’s current CEO, senior management and ...
9d
Starboard reportedly takes $1 billion stake in Pfizer, seeks changes
Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a ...
5d
Pfizer and Starboard Value, Tesla Robotaxi Day: Market Domination Overtime
On today's episode of Market Domination Overtime, hosts Julie Hyman and Josh Lipton delve into the top stories following ...
5d
on MSN
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
5d
Wall Street Lunch: Tug-Of-War For Fed With CPI Vs. Claims
September CPI rose 0.2%; Weekly jobless claims at 258k. Domino's Pizza misses slightly on revenue, sets cautious guidance; ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Pfizer
Albert Bourla
Frank D'Amelio
Ian Read
Feedback